Viveve Overview
- Year Founded
-
1987
- Status
-
Public
- Employees
-
47
- Stock Symbol
-
VIVE
- Investments
-
1
Viveve General Information
Description
Viveve Medical Inc designs, develops, manufactures and markets a platform medical technology. Its Cryogen-cooled Monopolar Radiofrequency technology is delivered through a radiofrequency generator, handpiece and treatment tip, called the Viveve System. The Viveve System is for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The Viveve System is indicated for use and being marketed for use in general surgical procedures for electrocoagulation and hemostasis in the United States. It has a business presence in the US, Asia Pacific, Canada, Europe and Middle East and Latin America.
Contact Information
Website
www.viveve.comCorporate Office
- 345 Inverness Drive South
- Building B, Suite 250
- Englewood, CO 80112
- United States
Corporate Office
- 345 Inverness Drive South
- Building B, Suite 250
- Englewood, CO 80112
- United States
Viveve Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.29K | 1.53K |
Viveve Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 3,518 | (5,400) | 6,900 | 27,179 |
| Revenue | 6,826 | 6,426 | 5,479 | 6,567 |
| EBITDA | (20,426) | (19,323) | (18,865) | (36,247) |
| Net Income | (22,989) | (22,027) | (21,915) | (42,526) |
| Total Assets | 12,154 | 25,913 | 16,630 | 26,977 |
| Total Debt | 5,881 | 5,349 | 5,993 | 4,251 |
Viveve Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Viveve Comparisons
Industry
Financing
Details
000000
000000
Viveve Competitors (17)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Angiodynamics | Private Debt Financed | Latham, NY | 000 | 00000 | 000000000 00 | 00000 |
| CooperSurgical | Corporate Backed or Acquired | Trumbull, CT | 0000 | |||
| Encision | Corporation | Boulder, CO | 00 | 00.000 | 000000000 - | 00.000 |
| Minerva (Therapeutic Devices) | Formerly VC-backed | Santa Clara, CA | 000 | 00000 | 000000000 | 00000 |
| Cutera | Formerly VC-backed | Brisbane, CA | 000 | 000.00 | 00000000 | 000.00 |
Viveve Patents
Viveve Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022200581-A1 | Therapeutic methods for treating tissue | Pending | 29-Jan-2021 | ||
| AU-2019204574-A1 | Methods for treating urinary stress incontinence | Inactive | 27-Jun-2018 | 000000000 | |
| US-20180333211-A1 | System for endovaginal delivery of therapeutic energies | Inactive | 19-May-2017 | 000000000 | |
| US-20220151826-A1 | Therapeutic methods for treating tissue | Pending | 31-Jan-2017 | 00000000 | |
| US-20180214304-A1 | Devices for dual mechanism aesthetic treatment and methods of use thereof | Inactive | 31-Jan-2017 | A61F7/12 |
Viveve Executive Team (9)
| Name | Title | Board Seat |
|---|---|---|
| Scott Durbin | Chief Executive Officer & Board Member | |
| Jim Robbins | Chief Financial Officer, Finance & Chief Accounting Officer, Accounting | |
| Gary Kaiser | Vice President of Global Marketing | |
| Marty Kerber | Vice President of Research, Development, and Operations |
Viveve Board Members (12)
| Name | Representing | Role | Since |
|---|---|---|---|
| Arlene Morris | Self | Board Member | 000 0000 |
| Deborah Jorn | Self | Board Member | 000 0000 |
| Scott Durbin | Viveve | Chief Executive Officer & Board Member | 000 0000 |
| Sharon Presnell Ph.D | Self | Board Member | 000 0000 |
| Steven Basta | Self | Chairman & Board Member | 000 0000 |
Viveve Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Viveve Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Viveve Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| PLC Medical Systems | 23-Sep-2014 | 0000000000 | Diagnostic Equipment | 00000000 |
Viveve ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
Viveve FAQs
-
When was Viveve founded?
Viveve was founded in 1987.
-
Who is the CEO of Viveve?
Scott Durbin is the CEO of Viveve.
-
Where is Viveve headquartered?
Viveve is headquartered in Englewood, CO.
-
What is the size of Viveve?
Viveve has 47 total employees.
-
What industry is Viveve in?
Viveve’s primary industry is Surgical Devices.
-
Is Viveve a private or public company?
Viveve is a Public company.
-
What is Viveve’s stock symbol?
The ticker symbol for Viveve is VIVE.
-
What is the current market cap of Viveve?
The current market capitalization of Viveve is $4.29K.
-
What is Viveve’s current revenue?
The trailing twelve month revenue for Viveve is $6.83M.
-
Who are Viveve’s competitors?
Angiodynamics, CooperSurgical, Encision, Minerva (Therapeutic Devices), and Cutera are some of the 17 competitors of Viveve.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
